优化基层医疗工具管理尿失禁(OPTIMA):整群随机对照试验方案
本研究为实用型整群随机对照试验,在四家南加州医疗系统内按诊所随机分配,比较四合一尿失禁干预与常规基层照护对提供者尿失禁照护质量的影响。主要结局为6个月病历审查中13项质量指标的依从性,计划纳入720例患者。
要点
- 干预包含学术 detailing、临床决策支持、共同管理与电子转诊服务四部分。
- 主要提供者结局为6个月病历审查中13项尿失禁质量指标的依从性。
- 计划纳入720例患者(每臂360例,每诊所平均15例)以保证足够把握度。
核心结论
- 研究旨在确定基于实践的综合干预对基层提供者尿失禁照护质量的效果与影响。
研究设计与样本
- 实用型整群随机对照试验,在四家南加州医疗系统内按诊所层面随机分配。
- 干预组24家诊所、72名提供者;非干预常规基层照护组24家诊所、72名提供者。
- 计划纳入720例患者,每臂360例,每诊所平均15例。
主要发现
- 主要提供者结局为6个月病历审查中13项质量指标的依从性。
- 次要提供者结局包括专科转诊率(总体专科转诊及适当延迟转诊的存在)和骨盆底认知与知识调查(PFAKS)测量的疾病特异性知识。
- 患者自报结局包括PFAKS疾病特异性知识、ICIQ-SF与UDI-6测量的尿失禁严重程度、PGI-I测量的治疗反应及SDM-Q-9测量的共享决策感知。
- 患者结局在就诊后基线、3个月和6个月时间点测量。
关键数值与推荐
- 干预包括学术 detailing 与医生教育及个体绩效反馈、临床决策支持(笔记模板、医嘱集、电子病历弹窗提醒)、与专职高级实践提供者共同管理及专家筛查转诊适当性的电子转诊服务。
临床怎么用
- 该方案可为基层提供者尿失禁管理的多组分实践干预设计提供参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The burden of urinary incontinence (UI) on the American public is great. The impact of this condition will only continue to rise as the population ages, yet the quality of care provided at the primary care level has been inadequate to date. The Optimizing Primary Care Tools for Incontinence MAnagement (OPTIMA) study has been designed as a four-pronged, practice-based incontinence intervention aimed at improving the management of UI by primary care providers (PCP). METHODS: In this pragmatic cluster randomized controlled trial, providers across four Southern California healthcare systems are randomized at the office level to receive incontinence intervention (n = 24 offices; 72 providers) vs. a non-intervention routine primary care cohort (n = 24 offices; 72 providers). The intervention includes (i) academic detailing with physician education and individual performance feedback; (ii) clinical decision support with note templates, order sets, and pop-up EHR alerts; (iii) access to co-management with a dedicated advanced practice provider; and (iv) implementation of an electronic referral service in which a specialist screens referrals for appropriateness. To achieve adequate power, the study will require 720 patients (360 patients per arm, average of 15 patients per office). The primary provider outcome is the quality of UI care, as measured by adherence to a set of 13 quality indicators (QIs) on a 6-month chart review. Secondary provider outcomes include specialty referral rates (overall specialist referrals and presence of appropriate delay of referral) and disease-specific knowledge measured by the Pelvic Floor Awareness and Knowledge Survey (PFAKS). Patient self-reported outcomes include disease-specific knowledge measured by PFAKS, UI severity measured by the International Consultation on Incontinence Questionnaire (ICIQ-SF) and Urinary Distress Inventory (UDI-6), UI response to therapy measured by Patient Global Impression of Improvement (PGI-I), and patient-perceived shared decision making via the 9-item Shared Decision Making Questionnaire (SDM-Q-9). Patient outcomes are measured at baseline, 3-, and 6-month timepoints post-appointment with the study provider. DISCUSSION: We expect this study to determine the efficacy and impact of comprehensive practice-based interventions on provider quality for UI care. TRIAL REGISTRATION: The study is registered at ClinicalTrials.gov (NCT05534412). Registered on August 1, 2022.
引用
- Moore MB, Okamuro K, Bresee C, et al. Optimizing Primary Care Tools for Incontinence MAnagement (OPTIMA): protocol for a cluster randomized controlled trial. Trials. 2026. PMID: 41882689. doi:10.1186/s13063-026-09427-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。